In addition to the already existing clinical development centered around rare diseases, development of oligonucleotide therapeutics for common diseases and intractable diseases such as cancer is ...
Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. The finding, by The University of ...
SYDNEY & BENTLEY, Australia--(BUSINESS WIRE)--SpeeDx Pty, Ltd. a developer of innovative molecular diagnostic solutions announced investment in SynGenis Pty Ltd., an experienced oligonucleotide ...
A team of biochemists at the Manchester Institute of Biotechnology has developed an isothermal biocatalytic process that can be used to manufacture therapeutic oligonucleotides in large volumes. In ...
The successful application of RNA therapies to rare diseases, neurological disorders, and other conditions as well as the plethora of biopharmaceutical companies developing new RNA-based therapeutics, ...
With oligonucleotides on the rise to treat rare diseases and cancers, Japanese manufacturer Nitto Denko is laying big plans. Nitto will plug a whopping 25 billion yen ($225.93 million) into its ...
8d
Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand
Opportunities center on integrated development-to-commercial manufacturing for complex RNA medicines, including GMP scale-up, analytical/QC, regulatory support and sterile fill-finish. Demand is ...
Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space The 41,000-square-foot-site will produce cGMP cell and gene therapy reagents, including single guide RNAs ...
Driven by Promise of miRNA and siRNA for Therapeutic and Research Applications Even as new players join the competitive market for research- and pharmaceutical-grade oligonucleotides, acquisitions and ...
The European Medicines Agency (EMA) want to set clear quality guidelines for drug companies manufacturing synthetic peptides and oligonucleotides. EMA raised the idea of specific guidelines for such ...
DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030" report has been added to ...
Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results